Atorvastatin's market dominance was driven by a pivotal 1997 FDA rule change allowing direct-to-consumer ads. Pfizer's marketing team treated the drug not as a medical compound, but as a consumer product like Nike, creating massive patient-led demand.

StackBlitz launched its pivotal product, Bolt.new, under a new brand because it was a final experiment before potentially shutting down. This strategy protects the core company's brand equity in case the experiment fails and gives the new product a distinct identity to attract a different user base.

Adderall's success proves a core chemical patent isn't essential for market dominance. A strong brand that becomes synonymous with a condition, combined with secondary patents on novel delivery mechanisms (like Adderall XR's capsule), can create a durable, highly profitable business moat.

The most compelling reason to initiate a rebrand isn't a desire for a refresh, but when your name no longer reflects what you do. When the name is tied to a service that's now a fraction of your business, it becomes a clear, non-negotiable guardrail that forces the difficult decision to change.

To find a single viable drug name, agencies like Brand Institute generate an initial list of 300 to 500 concepts. This massive brainstorming effort highlights the scale of the creative process, with the vast majority of ideas being rejected long before regulatory review.

The 1988 launch of Prozac marked a major shift in pharmaceutical branding. Its name was a non-descriptive "empty vessel" designed for marketing impact ('pro' for positive, 'zac' for energy), moving away from names that explained a drug's function.

Pharmaceutical companies often mistakenly believe they lack content. The real issue is the underutilization of existing assets. By redefining, reformatting, or simply changing the visual style of old content, teams can deliver fresh experiences without starting from scratch, a key strategy for established brands.

Despite expanding beyond takeaways into retail and pharmaceuticals, Just Eat Takeaway keeps its name. The immense brand recognition is more valuable than a name that literally describes all its services. They educate customers on new offerings gradually, leveraging existing brand trust.

Unlike consumer-facing drugs, many cancer therapies have names derived from their scientific mechanism of action. This is a deliberate strategy to communicate the drug's uniqueness and resonate with the true target audience: oncologists who understand the science.